New Insights Into the Comorbidity of Coronary Heart Disease and Depression

被引:48
作者
Wu, Yeshun
Zhu, Bin
Chen, Zijun
Duan, Jiahao
Luo, Ailin
Yang, Ling
Yang, Chun
机构
基金
中国国家自然科学基金;
关键词
ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; GROWTH-FACTOR; 21; CARDIOVASCULAR-DISEASE; GUT-MICROBIOTA; NEUROTROPHIC FACTOR; MAJOR DEPRESSION; RATE-VARIABILITY; SEROTONIN TRANSPORTER; MEDICATION ADHERENCE;
D O I
10.1016/j.cpcardiol.2019.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary heart disease (CHD) and depression are common disorders that markedly impair quality of life and impose a great financial burden on society. They are also frequently comorbid, exacerbating patient condition, and worsening prognosis. This comorbidity strongly suggests shared pathologic mechanisms. This review focuses on the incidence of depression in patients with CHD, deleterious effects of depression on CHD symptoms, and the potential mechanisms underlying comorbidity. In addition to the existing frequent mechanisms that are well known for decades, this review summarized interesting and original potential mechanisms to underlie the comorbidity, such as endocrine substances, gut microbiome, and microRNA. Finally, there are several treatment strategies for the comorbidity, involving drugs and psychotherapy, which may provide a theoretical basis for further basic research and clinical investigations on improved therapeutic interventions.
引用
收藏
页数:31
相关论文
共 50 条
  • [1] Depression and coronary heart disease
    Carney, Robert M.
    Freedland, Kenneth E.
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (03) : 145 - 155
  • [2] Depression. An underestimated risk for the development and progression of coronary heart disease
    Ladwig, K. H.
    Emeny, R. T.
    Haefner, S.
    Lacruz, M. E.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2011, 54 (01) : 59 - 65
  • [3] Depression and coronary heart disease: mechanisms, interventions, and treatments
    Xu, Linjie
    Zhai, Xu
    Shi, Dazhuo
    Zhang, Ying
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [4] Depression Related Pathophysiologies Relevant in Heart Disease: Insights into the Mechanism Based on Pharmacological Treatments
    Varghese, Treesa P.
    Kumar, Anand V.
    Varghese, Nila M.
    Chand, Sharad
    CURRENT CARDIOLOGY REVIEWS, 2020, 16 (02) : 125 - 131
  • [5] Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease
    Carney, Robert M.
    Freedland, Kenneth E.
    Steinmeyer, Brian
    Rubin, Eugene H.
    Mann, Douglas L.
    Rich, Michael W.
    PSYCHOSOMATIC MEDICINE, 2016, 78 (01): : 49 - 59
  • [6] Depression in People with Coronary Heart Disease: Prognostic Significance and Mechanisms
    Dickens, Chris
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (10)
  • [7] New Perspectives on Treatment of Depression in Coronary Heart Disease
    Carney, Robert M.
    Freedland, Kenneth E.
    PSYCHOSOMATIC MEDICINE, 2023, 85 (06): : 474 - 478
  • [8] Depression as a risk factor for adverse outcomes in coronary heart disease
    Freedland, Kenneth E.
    Carney, Robert M.
    BMC MEDICINE, 2013, 11
  • [9] Nighttime heart rate predicts response to depression treatment in patients with coronary heart disease
    Carney, Robert M.
    Freedland, Kenneth E.
    Steinmeyer, Brian C.
    Rubin, Eugene H.
    Stein, Phyllis K.
    Rich, Michael W.
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 200 : 165 - 171
  • [10] Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: A meta-analysis
    Tully, Phillip J.
    Cosh, Suzanne M.
    JOURNAL OF HEALTH PSYCHOLOGY, 2013, 18 (12) : 1601 - 1616